PFC
Poplar Forest Capital Portfolio holdings
AUM
$563M
This Quarter Return
+5.76%
1 Year Return
+8.43%
3 Year Return
+29.99%
5 Year Return
+205.2%
10 Year Return
+230.46%
AUM
$1.01B
AUM Growth
+$1.01B
(+7.4%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
44.36%
Holding
54
New
5
Increased
23
Reduced
8
Closed
2
Top Buys
| 1 |
MetLife
MET
|
$12.3M |
| 2 |
DNB
Dun & Bradstreet
DNB
|
$11M |
| 3 |
RDC
Rowan Companies Plc
RDC
|
$10.5M |
| 4 |
Quest Diagnostics
DGX
|
$9.52M |
| 5 |
Citigroup
C
|
$5.46M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$13.5M |
| 2 |
TE Connectivity
TEL
|
$12.4M |
| 3 |
Xerox
XRX
|
$10.5M |
| 4 |
Alcoa
AA
|
$9.18M |
| 5 |
Bank of America
BAC
|
$5.33M |
Sector Composition
| 1 | Financials | 33.31% |
| 2 | Technology | 17.37% |
| 3 | Energy | 10.57% |
| 4 | Healthcare | 10.1% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aecom
ACM
$16.5B
| $20.2M | 2.01% | 628,551 +28,490 | +5% | +$917K |
|
|
27
Alcoa
AA
$8.33B
| $19.6M | 1.95% | 1,315,328 -616,216 | -32% | -$9.18M |
|
28
Reliance Steel & Aluminium
RS
$15.5B
| $15.3M | 1.52% | 206,897 +43,159 | +26% | +$3.18M |
|
|
URS
29
DELISTED
URS CORP
URS
| $14.7M | 1.46% | 321,074 +113,512 | +55% | +$5.2M |
|
|
DNB
30
DELISTED
Dun & Bradstreet
DNB
| $11M | 1.09% | +99,688 | New | +$11M |
|
|
RDC
31
DELISTED
Rowan Companies Plc
RDC
| $10.5M | 1.04% | +328,398 | New | +$10.5M |
|
|
32
Quest Diagnostics
DGX
$20.3B
| $9.52M | 0.95% | +162,177 | New | +$9.52M |
|
|
DNY
33
DELISTED
DONNELLEY R R & SONS CO
DNY
| $9.28M | 0.92% | 547,367 +47,026 | +9% | +$798K |
|
34
Procter & Gamble
PG
$368B
| $2.58M | 0.26% | 32,784 | – | – |
|
35
Pfizer
PFE
$141B
| $2.48M | 0.25% | 83,480 | – | – |
|
36
3M
MMM
$82.8B
| $2.26M | 0.22% | 15,760 | – | – |
|
37
Johnson & Johnson
JNJ
$427B
| $2.15M | 0.21% | 20,579 | – | – |
|
38
Bristol-Myers Squibb
BMY
$96B
| $1.49M | 0.15% | 30,730 | – | – |
|
39
Emerson Electric
EMR
$74.3B
| $1.48M | 0.15% | 22,355 | – | – |
|
40
IBM
IBM
$227B
| $1.1M | 0.11% | 6,060 | – | – |
|
41
AbbVie
ABBV
$372B
| $1.07M | 0.11% | 18,990 | – | – |
|
42
Abbott
ABT
$231B
| $777K | 0.08% | 18,990 | – | – |
|
43
GSK
GSK
$79.9B
| $730K | 0.07% | 13,656 | – | – |
|
44
PepsiCo
PEP
$204B
| $729K | 0.07% | 8,160 | – | – |
|
45
Exxon Mobil
XOM
$487B
| $556K | 0.06% | 5,520 | – | – |
|
46
Oracle
ORCL
$635B
| $358K | 0.04% | 8,837 | – | – |
|
47
SPDR S&P 500 ETF Trust
SPY
$658B
| $353K | 0.04% | 1,803 +106 | +6% | +$20.8K |
|
48
Chevron
CVX
$324B
| $330K | 0.03% | 2,528 | – | – |
|
49
Humana
HUM
$36.5B
| $275K | 0.03% | 2,150 | – | – |
|
50
Progressive
PGR
$145B
| $216K | 0.02% | 8,500 | – | – |
|